scholarly journals One-On-One: Kathleen Noonan

2019 ◽  
pp. 14-19
Keyword(s):  
Patient Safety ◽  
Health Policy ◽  
Policy Change ◽  
Chief Executive Officer ◽  
Real World ◽  
Healthcare Providers ◽  
Chief Executive ◽  
Social Needs ◽  
World Health ◽  
The City

Kathleen Noonan is chief executive officer of the Camden Coalition of Healthcare Providers, a nonprofit, multidisciplinary healthcare innovator in Camden, New Jersey. A former corporate lawyer, Noonan previously was co-director of PolicyLab at Children’s Hospital of Philadelphia, which she co-founded in 2008 to ensure clinical research was connected to and influencing real-world health policy change. Noonan recently spoke with Cait Allen, MPH, director of Engagement at the Patient Safety Authority, about the Camden Coalition’s efforts to improve care for people with complex health and social needs in in the city of Camden, regionally, and across the country.

scholarly journals Transdisciplinary Translational Science for Youth Health and Wellness: Introduction to a Special Issue

2021 ◽  
Author(s):  
Ashley T. Scudder ◽  
Gregory J. Welk ◽  
Richard Spoth ◽  
Constance C. Beecher ◽  
Michael C. Dorneich ◽  
...  
Keyword(s):  
Real World ◽  
Social Needs ◽  
Research Network ◽  
World Health ◽  
Translational Science ◽  
Community Practice ◽  
Health And Wellness ◽  
Youth Health ◽  
Special Issue ◽  
Interdisciplinary Approaches

Abstract Background Transdisciplinary translational science applies interdisciplinary approaches to the generation of novel concepts, theories and methods involving collaborations among academic and non-academic partners, in order to advance the translation of science into broader community practice. Objective This paper introduces a special issue on transdisciplinary translational science for youth health and wellness. We provide an overview of relevant research paradigms, share the related goals of the Iowa State University Translational Research Network (U-TuRN), and introduce the specific papers in the issue. Method Authors were asked to submit empirical reports, programmatic reviews or policy-related papers that examined youth health issues from a transdisciplinary translational perspective. Results The papers included in this special issue each involve direct and fully-integrated community-university partnerships and collaborations between academic and non-academic partners in scholarship and research. Reports emphasize the value of the applied nature of the work with a research agenda driven primarily by real-world health and social needs. Conclusions There is growing acceptance of the need for transdisciplinary, community-university collaborative research approaches as a means to meet both the requirements posed by real-world problems as well as goals of advancing scientific knowledge and innovation. In this issue, readers will find papers that show the promise of rethinking existing conceptual frameworks to incorporate transdisciplinary approaches as a catalyst to addressing translational science questions related to the field of children and youth care.

scholarly journals Do We Feel Safe About the Surgical Safety Checklist? A Cross-Sectional Study Between Two Periods

2021 ◽  
Author(s):  
Danah Alsadun ◽  
Hassan Arishi ◽  
Abdullah Alhaqbani ◽  
Reema Alzighaibi ◽  
Emad Masuadi ◽  
...  
Keyword(s):  
Patient Safety ◽  
Positive Impact ◽  
Healthcare Providers ◽  
Cross Sectional Study ◽  
World Health ◽  
Sectional Study ◽  
Cross Sectional ◽  
Surgical Safety Checklist ◽  
Surgical Safety ◽  
Significant Difference

ABSTRACT Introduction The aim of this study was to evaluate the change in the healthcare providers' perceptions regarding the World Health Organization Surgical Safety Checklist (WHO SSC) and patient safety in the operating room (OR) at a tertiary hospital in Riyadh, Saudi Arabia. Methods This cross-sectional study was conducted at King Abdulaziz Medical City. Data were collected from two years (2011 and 2019) for comparison. The co-investigators distributed a self-administered Likert scale questionnaire in the various operating areas (35 ORs). Results The total sample was 461. Number of participants enrolled from both years was 235 (51%) and 226 (49%), respectively. The results indicated a statistically significant difference in the attitude of the participants regarding all aspects of patient safety in the OR when the two periods were compared (p < 0.001). Similarly, healthcare providers' perceptions regarding the importance of the WHO SSC increased from 50% (2011) excellent to 68% excellent (2019) (p < 0.001). Conclusions Currently, more healthcare providers recognize the importance of the WHO SSC, and more have a positive attitude toward teamwork, communication, and feeling free to speak out when surgical safety is compromised. All of these cultural changes have positive impact on the overall safety of the OR; however, there are still aspects requiring improvement to provide a safer OR and surgery. Educational interventions regarding the importance of communication and teamwork would improve the safety of surgical care in the OR.

scholarly journals Real-world research into digital health interventions: adapting World Health Organization Classifications to enable surveys of healthcare professionals and clients (Preprint)

2020 ◽  
Author(s):  
Mark Merolli ◽  
Rana S Hinman ◽  
Belinda J Lawford ◽  
Dawn Choo ◽  
Kathleen Gray
Keyword(s):  
World Health Organization ◽  
Real World ◽  
Technology Use ◽  
Digital Health ◽  
Healthcare Providers ◽  
Health Interventions ◽  
World Health ◽  
Survey Method ◽  
Survey Instruments ◽  
Health Organization

BACKGROUND The advancement of digital health has widened the scope of technology use across multiple frontiers of healthcare services, ranging from personalized therapeutics, mHealth, electronic health record management to telehealth consultations. The World Health Organization (WHO) responded to this by publishing in 2018 an inaugural broad classification framework of Digital Health Interventions (DHIs) used to address contemporary health system needs. OBJECTIVE : The present study describes the adaptation of the WHO framework for application in real-world research to build on this work. The aim is to support the study of clients’ (patients) and healthcare providers’ willingness to engage with a range of technologies in specific health context s via survey method. The study also explores issues of acceptability, experiences, and uptake in a way that is user-friendly for both clients and healthcare providers, systematic (for researchers) and meaningful (for research participants). METHODS Using a qualitative item review approach, WHO DHI descriptors were adapted and refined systematically to be used in survey form. This has been designed to align with the processes of delivering and receiving care in clinical practice; using musculoskeletal physiotherapy as a practical case scenario. RESULTS The adapted descriptor items were incorporated into complementary research survey instruments (for healthcare providers and clients), which will be used in a larger cross-sectional study exploring the willingness of both parties to use digital technologies in management of musculoskeletal conditions. CONCLUSIONS This study builds on the WHO standardized DHI framework. We adapted and refined functions of DHIs to develop dual novel survey instruments that can be deployed to explore the perceived usefulness and application of DHIs for different clinical care functions. Researchers may wish to use these survey instruments to examine digital health use systematically in a variety of clinical fields or technology scenarios in a way that is standardized and generalizable. CLINICALTRIAL Not Applicable

scholarly journals Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Varunika Ruwanpura ◽  
Josselyn Neukom ◽  
Koen Peeters Grietens ◽  
Ric N. Price ◽  
Kamala Thriemer ◽  
...  
Keyword(s):  
Health Policy ◽  
Policy Change ◽  
Malaria Elimination ◽  
Vivax Malaria ◽  
Policy Making ◽  
Treatment Guidelines ◽  
Economic Status ◽  
Critical Role ◽  
World Health ◽  
Asia Pacific

Abstract Background The changing global health landscape has highlighted the need for more proactive, efficient and transparent health policy-making. After more than 60 years of limited development, novel tools for vivax malaria are finally available, but need to be integrated into national policies. This paper maps the malaria policy-making processes in seven endemic countries, to identify areas where it can be improved to align with best practices and optimal efficiency. Methods Data were collected during a workshop, convened by the Asia Pacific Malaria Elimination Network’s Vivax Working Group in 2019, and subsequent interviews with key stakeholders from Cambodia, Ethiopia, Indonesia, Pakistan, Papua New Guinea (PNG), Sri Lanka and Vietnam. Documentation of policy processes provided by respondents was reviewed. Data analysis was guided by an analytic framework focused on three a priori defined domains: “context,” “actors” and “processes”. Results The context of policy-making varied with available funding for malaria, population size, socio-economic status, and governance systems. There was limited documentation of the process itself or terms of reference for involved actors. In all countries, the NMP plays a critical role in initiating and informing policy change, but the involvement of other actors varied considerably. Available evidence was described as a key influencer of policy change; however, the importance of local evidence and the World Health Organization’s endorsement of new treatments and diagnostics varied. The policy process itself and its complexity varied but was mostly semi-siloed from other disease specific policy processes in the wider Ministry of Health. Time taken to change and introduce a new policy guideline previously varied from 3 months to 3 years. Conclusions In the medium to long term, a better alignment of anti-malarial policy-making processes with the overall health policy-making would strengthen health governance. In the immediate term, shortening the timelines for policy change will be pivotal to meet proposed malaria elimination milestones.

Issues Impacting Therapeutic Outcomes in Pediatric Patients: An Overview

2014 ◽  
Vol 10 (3) ◽  
pp. 184-193 ◽  
Author(s):  
Atin Kalra ◽  
Shishu Goindi
Keyword(s):  
Pediatric Patients ◽  
Healthcare Providers ◽  
World Health Organisation ◽  
Dosage Forms ◽  
World Health ◽  
Neglected Diseases ◽  
Therapeutic Outcomes ◽  
Immunodeficiency Virus ◽  
Academic Researchers ◽  
Child Friendly

The quest for achieving optimal therapeutic outcomes in pediatric patients has evaded the healthcare professionals for long and often lack of child specific dosage forms and the associated events that follow with it have been considered to be major contributor towards suboptimal outcomes. Consequently, there have been sustained efforts over the years to address this issue with the enactment of legislations like Best Pharmaceutical for Children Act (BPCA), Pediatric Research Equity Act (PREA) and Pediatric Regulation by European Union (EU) to incentivise the participation of pharmaceutical industry towards development of child friendly dosage forms. Initiatives taken in past by organisations like World Health Organisation (WHO) and Drugs for Neglected Diseases Initiative (DNDi) to spur the development of child friendly dosage forms has helped to address issues pertaining to management of Human Immunodeficiency Virus (HIV) and malaria in pediatric patients. Present efforts aimed at developing child friendly dosage forms include oro-dispersible platforms including thin films and mini-tablets. Despite these leaps and advancements in developing better dosage forms for children, lower therapeutic outcomes in pediatric patients continue to remain an unresolved issue because of detrimental effects of additional factors such as parents understanding of label instructions and complexities involved in executing pediatric clinical studies thus requiring a concerted effort from pharmaceutical companies, academic researchers, parents and healthcare providers to work for better treatment outcomes in children.

Peregrine—Twenty Years of Fraudulent Cash Balances

2013 ◽  
Vol 29 (2) ◽  
pp. 337-348
Author(s):  
Randal J. Elder ◽  
Diane J. Janvrin ◽  
Paul Caster
Keyword(s):  
Information System ◽  
Chief Executive Officer ◽  
Accounting Information ◽  
Chief Executive ◽  
Cash Balance ◽  
Accounting Information System

ABSTRACT In July 2012, Peregrine Financial Group filed for bankruptcy following the discovery that $215 million in customer balances had been embezzled. Investigation revealed that its Chief Executive Officer, Russell Wasendorf, Sr., fooled auditors and regulators for 20 years by preparing fictitious bank statements and cash balance confirmations to hide the theft of cash. The fraud was uncovered when Peregrine's regulator, the National Futures Association (NFA), demanded that Peregrine participate in an electronic confirmation process for verification of customer accounts. This case discusses how the fraud was allowed to go undetected for 20 years, the importance of auditing cash, and how new electronic confirmation technology improves the ability to authenticate confirmation responses. The case is suitable for use in both auditing and accounting information system courses.

scholarly journals Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Aline Bourdin ◽  
Marie Paule Schneider ◽  
Isabella Locatelli ◽  
Myriam Schluep ◽  
Olivier Bugnon ◽  
...  
Keyword(s):  
Patient Safety ◽  
Medication Adherence ◽  
Real World ◽  
Safety Data ◽  
Support Program ◽  
Patient Support ◽  
Patient Support Program ◽  
Dose Monitoring ◽  
Real World Evidence ◽  
Patient Reported

AbstractThe Fingolimod Patient Support Program (F-PSP) is an interprofessional specialty pharmacy service designed to ensure responsible use of fingolimod by promoting patient safety and medication adherence. This study aims to evaluate the safety and medication adherence of patients who joined the F-PSP between 2013 and 2016. Sociodemographic and medical characteristics, patient safety data (patient-reported symptoms, discontinuations due to adverse events (AEs), repeated first-dose monitoring), and medication adherence (implementation, persistence, reasons for discontinuation, influence of covariates, barriers and facilitators) were described. Sixty-seven patients joined the F-PSP. Patients reported a high frequency of symptoms. Due to AEs, 7 patients discontinued fingolimod, 3 took therapeutic breaks, and 1 reduced the regimen temporarily. Three patients repeated the first-dose monitoring. Patients had a high medication adherence over the 18-month analysis period: implementation decreased from 98.8 to 93.7%, and fingolimod persistence was 83.2% at 18 months. The patients’ level of education, professional situation, and living with child(ren) influenced implementation. Patients reported more facilitators of medication adherence than barriers. The F-PSP seems valuable for supporting individual patients (ensuring responsible use of fingolimod and inviting patients for shared-decision making) and public health (indirectly gathering real-world evidence).

scholarly journals Announcing Our New Chief Executive Officer

2021 ◽  
Vol 17 (3) ◽  
pp. 253
Author(s):  
Sophia L. Thomas
Keyword(s):  
Chief Executive Officer ◽  
Chief Executive

Pharmacy Leadership Amid the Pandemic: Maintaining Patient Safety During Uncertain Times

2021 ◽  
pp. 001857872110375
Author(s):  
Irene Derrong Lin ◽  
John B. Hertig
Keyword(s):  
Patient Safety ◽  
Safety Data ◽  
Clinical Effectiveness ◽  
World Health ◽  
Leadership Strategies ◽  
Pharmaceutical Supply Chain ◽  
The World ◽  
Health Organization ◽  
Pharmacy Leaders ◽  
Effective Treatments

The relentless surges of global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections that caused the Covid-19 disease had pressured researchers and regulators to develop effective treatments quickly. While studying these therapies amid the pandemic, threats to patient care were reported, including (1) maintaining adequate safeguards as clinical effectiveness and safety data evolves, (2) risks from online counterfeit medications, and (3) disruption of the global pharmaceutical supply chain. This article discusses these patient safety threats and suggests strategies that promote patient safety, foster medication intelligence, and mitigate drug shortages. As the world continues to develop safe and effective treatments for Covid-19, patient safety is paramount. In response to the World Health Organization (WHO) Global Safety Challenge: Medication Without Harm, leaders must establish effective approaches to improve medication safety during the pandemic. Successfully integrating these leadership strategies with current practices allows pharmacy leaders to implement robust systems to reduce errors, prevent harm, and advocate for patient safety.

Sign in / Sign up

Export Citation Format

Share Document